Clinical Trial – Zoster Eye Disease Study – Shingles

Answer 1

This is a multi-center, randomized, double-masked, clinical trial, led by New York University School of Medicine. The objective is to determine whether prolonged suppressive oral antiviral treatment reduces complications of  HZO (shingles in the eye). The result is helpful to improving clinical outcomes in this common disease.

Study Type :	Interventional  (Clinical Trial)
Estimated Enrollment :	1050 participants
Allocation:	Randomized
Intervention Model:	Parallel Assignment
Masking:	Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:	Treatment
Official Title:	Long-term Suppressive Valacyclovir Treatment for Herpes Zoster Ophthalmicus
Actual Study Start Date :	August 23, 2017
Estimated Primary Completion Date :	December 31, 2020
Estimated Study Completion Date :	December 31, 2020

Contacts

United States, Alabama
University of Alabama at Birmingham	Recruiting
Birmingham, Alabama, United States, 35233
Contact: Lindsay Gregg    205-488-0777    lindsaygregg@uabmc.edu
Principal Investigator: Priscilla Fowler, MD

 

ClinicalTrials.gov Identifier:

NCT03134196

For enrollment please visit www.clinicaltrials.gov.